Cargando…
Enzalutamide-induced signatures revealed by epigenetic plasticity using single-cell multi-omics sequencing in prostate cancer
Prostate cancer is morphologically and molecularly heterogeneous, which poses obstacles for early diagnosis and treatment. Advancements in understanding the heterogeneity of prostate cancer will help navigate through these challenges and ultimately benefit patients. In this study, we integrated sing...
Autores principales: | Fan, Huihui, Li, Jinze, Manuel, Astrid M., Zhao, Zhongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995291/ https://www.ncbi.nlm.nih.gov/pubmed/36910711 http://dx.doi.org/10.1016/j.omtn.2023.02.022 |
Ejemplares similares
-
Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning
por: de Jong, Anouk C., et al.
Publicado: (2023) -
Tribbles 2 pseudokinase confers enzalutamide resistance in prostate cancer by promoting lineage plasticity
por: Monga, Jitender, et al.
Publicado: (2021) -
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease
por: Smith, Rebecca, et al.
Publicado: (2020) -
An epigenetic and transcriptomic signature of immune tolerance in human monocytes through multi-omics integration
por: Brands, Xanthe, et al.
Publicado: (2021) -
Identification of Epigenetic-Dysregulated lncRNAs Signature in Osteosarcoma by Multi-Omics Data Analysis
por: Huang, Junchao, et al.
Publicado: (2022)